Bioinformatics Market Size
| Study Period | 2019 - 2029 |
| Market Size (2024) | USD 16.36 Billion |
| Market Size (2029) | USD 23.97 Billion |
| CAGR (2024 - 2029) | 7.94 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Bioinformatics Market Analysis
The Bioinformatics Market size is estimated at USD 16.36 billion in 2024, and is expected to reach USD 23.97 billion by 2029, growing at a CAGR of 7.94% during the forecast period (2024-2029).
The impact of COVID-19 on the market's growth was substantial in its preliminary phase. Sequencing and data analysis were termed useful tools for the characterization and detection of viruses in the environment, animals, and people during the pandemic, thereby resulting in higher usage of such computational technology across several research platforms. Information related to transmission chains was critical for public health control and containment measures, while knowledge of virus variability guided the development of vaccines and cheaper diagnostic methods. Thus, as per the analysis, the market is expected to follow the same trend over the post-pandemic phase due to emerging strains of the SARS-CoV-2 virus and an increase in research and development activities. For instance, in November 2021, Illumina donated sequencing consumables and cloud-based bioinformatics to Canadian COVID-19 projects. The donations were to support the HostSeq and VirusSeq projects of Canada's COVID-19 Genomics Network, or CanCoGen. Thus, such initiatives by the market players are anticipated to support the market's growth during the forecast period.
The growth factors for the bioinformatics market include the rising demand for nucleic acid and protein sequencing, rising initiatives from private and government organizations, the accelerating growth of proteomics and genomics, and rising research on molecular biology and drug discovery. Owing to the above factors, the global bioinformatics market is expected to experience rapid growth during the forecast period.
In July 2021, the National Institute of Technology, Rourkela (NIT-R), India, launched its Center for Bioinformatics and Computational Biology (CBCB), which will help develop novel disease biomarkers and therapeutic strategies using big data analysis. Thus, the launch of such centers using computational biology in developing countries is boosting the market growth.
Additionally, according to the data published in Mid-Year Review: New Drug Approvals in June 2021, the US FDA and Center for Drug Evaluation and Research (CDER) have authorized 26 new molecular entities (NMEs) at the halfway point of 2021 (as of June 28, 2021), which was on par with the full-year 2020 approval rate of 53 times. Except for 2018, when 59 NMEs were granted, the number of NMEs approved in 2020 was the second-highest in the last decade. The rising approvals from the FDA will further boost the research and development activities, which will in turn need databases and software to ease the process of drug design and development, in turn boosting the market's growth. Moreover, the introduction of technologically advanced bioinformatics software such as BALL, Bioclipse, RasMol, and AUTODOCK and the rising market usage of these tools for effective and accurate analysis of biomarker discovery programs that assist in toxicity detection during the initial stage of the drug development process is expected to boost the industry's growth over the upcoming years. For instance, in June 2022, My Intelligent Machines (MIMs) launched powerful software for drug development in oncology.
However, the lack of well-defined standards and common data formats for the integration of data and concerns about data complexity, as well as the shortage of user-friendly tools, are likely to hamper market growth over the forecast period.
Bioinformatics Market Trends
This section covers the major market trends shaping the Bioinformatics Market according to our research experts:
Sequence Analysis Platform Segment is Expected Hold a Significant Share Over the Forecast Period
In bioinformatics, sequence analysis is the process of subjecting a DNA, RNA, or peptide sequence to any of a wide range of analytical methods to understand its features, function, structure, or evolution. The advancements in next-generation sequencing (NGS) technologies regarding throughput, read length, and accuracy had a major impact on microbiome (genetic) research. These advancements have significantly improved 16S rRNA amplicon sequencing.
Commercially available platforms, like Illumina MiSeq, Ion Torrent PGM, and Roche 454 GS FLX Titanium, are equipped with standard and modified library preparation protocols. These sequencing and analysis platforms can reduce sequencing errors by bioinformatically removing chimeras and other sequencing artifacts from 16S rRNA amplicon sequences generated by pyrosequencing. Such advantages of sequence analysis in the bioinformatics market are expected to propel the growth of the market segment.
Furthermore, several market players have been utilizing sequence analysis platforms for various R&D studies. For instance, in December 2021, Singular Genomics Systems Inc. announced the commercial launch of the G4, the world's most powerful benchtop sequencer. The next-generation sequencing platform featured novel high-performance chemistry and advanced engineering to deliver accuracy, flexibility, speed, and power for a range of applications, including research in oncology and immunology.
Overall, the market for the sequence analysis platform segment is expected to witness significant growth over the forecast period, primarily due to an increase in the utilization of next-generation sequencing.
North America Witnessed the Healthy Growth and is Expected To Follow the Same Trend over the Forecast Period
The North American region is leading the market due to factors such as the rise in the number of research activities pertaining to nucleic acids and genetic engineering, the increase in the budget for novel drug discovery using proteomic and metagenomic approaches, and growing awareness about biological data. The increasing innovations in molecular biology procedures, the high adoption rate of new healthcare technologies, and the high prevalence of genomic and proteomic research studies are the primary drivers for the bioinformatics market in the region.
The United States contributes heavily to the research being conducted in the fields of drug discovery, genomics, and proteomics structure prediction. Various universities and research institutes have received funding from government organizations, like the National Institute of Health (NIH), and private organizations, like Gates and Melinda Foundation, for developing various bioinformatics tools and devices that can handle the bulk amount of data being generated to understand the disease prognosis and treatment options. Since the amount of genomic and proteomic data being generated is high in the United States, there are huge investments to cater to the database development and management of biological data in the country. Moreover, large-scale investments are being made in public and private research for gene therapy and drug development purposes since consumers in the United States are paying more for newer drugs. Due to consumers' shifting preferences for new drugs, research institutes are continuously engaging in novel drug discovery.
In April 2022, ATCC announced an agreement with Qiagen to provide them with sequencing data from its collection of animal and human cell lines and biological materials. Qiagen is expected to establish a database from the information to develop and deliver high-value digital biology content for the biotechnology and pharmaceutical industries, enabling the use of authenticated biological data sets to uncover new disease pathways and discover novel therapeutic targets. Such developments in the United States region are adding to the growth of the studied market.
Hence, owing to the above-mentioned factors, the market is expected to grow exponentially in the North American region.
Bioinformatics Industry Overview
The bioinformatics market is competitive with the presence of several market players. In terms of market share, a few of the major players currently dominate the market. However, with technological advancements and product innovations, mid-size to smaller companies are increasing their market presence by introducing new products. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others.
Bioinformatics Market Leaders
-
Illumina Inc.
-
Thermo Fischer Scientific
-
Qiagen NV
-
PerkinElmer
-
Agilent Technologies
*Disclaimer: Major Players sorted in no particular order
Bioinformatics Market News
- In June 2022, California's biotechnology research startup LatchBio launched an end-to-end bioinformatics platform for handling big biotech data to accelerate scientific discovery.
- In March 2022, ARUP launched Rio, a bioinformatics pipeline and analytics platform for better, faster next-generation sequencing test results.
Bioinformatics Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Increasing Demand for Nucleic Acid and Protein Sequencing
- 4.2.2 Increasing Initiatives from Governments and Private Organizations
- 4.2.3 Accelerating Growth of Proteomics and Genomics
- 4.2.4 Increasing Research on Molecular Biology and Drug Discovery
-
4.3 Market Restraints
- 4.3.1 Lack of Well-defined Standards and Common Data Formats for Integration of Data
- 4.3.2 Data Complexity Concerns and Lack of User-friendly Tools
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
-
5.1 By Products and Services
- 5.1.1 Knowledge Management Tools
- 5.1.2 Bioinformatics Platform
- 5.1.2.1 Sequence Analysis Platform
- 5.1.2.2 Sequence Alignment Platform
- 5.1.2.3 Sequence Manipulation Platform
- 5.1.2.4 Structural and Functional Analysis Platform
- 5.1.2.5 Other Bioinformatics Platforms
- 5.1.3 Bioinformatics Services
- 5.1.3.1 Sequencing Services
- 5.1.3.2 Database and Management Services
- 5.1.3.3 Data Analysis
- 5.1.3.4 Other Bioinformatics Services
-
5.2 By Application
- 5.2.1 Microbial Genome
- 5.2.2 Gene Engineering
- 5.2.3 Drug Development
- 5.2.4 Omics
- 5.2.5 Personalized Medicine
- 5.2.6 Other Applications
-
5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 3rd Millennium Inc.
- 6.1.2 ABM
- 6.1.3 Agilent Technologies
- 6.1.4 BioWisdom Ltd
- 6.1.5 Quest Diagnostics (Celera Corporation)
- 6.1.6 Dassault Systèmes
- 6.1.7 Data4Cure
- 6.1.8 Geneva Bioinformatics SA
- 6.1.9 Illumina Inc.
- 6.1.10 Lineage Cell Therapeutics (BioTime Inc.)
- 6.1.11 Ontoforce
- 6.1.12 PerkinElmer
- 6.1.13 Qiagen NV
- 6.1.14 Rosetta Biosoftware
- 6.1.15 Thermo Fischer Scientific (Life Technologies)
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityBioinformatics Industry Segmentation
As per the scope of the report, bioinformatics is the application of computational technology to gather, store, analyze, and integrate biological data. This data is used to procure information and is applied to gene-based drug discovery and development, protein structure studies, and the determination of the therapeutic efficacy of drugs. The Bioinformatics Market is Segmented by Products and Services (Knowledge Management Tools, Bioinformatics Platform (Sequence Analysis Platform, Sequence Alignment Platform, Sequence Manipulation Platform, Structural and Functional Analysis Platform, Other Bioinformatics Platforms) and Bioinformatics Services (Sequencing Services, Database and Management Services, Data Analysis, Other Bioinformatics Services)), Applications (Microbial Genome, Gene Engineering, Drug Development, Personalized Medicine, Omics, and Other Applications), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally. The report offers the value (in USD million) for the above segments.
| By Products and Services | Knowledge Management Tools | |
| Bioinformatics Platform | Sequence Analysis Platform | |
| Sequence Alignment Platform | ||
| Sequence Manipulation Platform | ||
| Structural and Functional Analysis Platform | ||
| Other Bioinformatics Platforms | ||
| Bioinformatics Services | Sequencing Services | |
| Database and Management Services | ||
| Data Analysis | ||
| Other Bioinformatics Services | ||
| By Application | Microbial Genome | |
| Gene Engineering | ||
| Drug Development | ||
| Omics | ||
| Personalized Medicine | ||
| Other Applications | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East and Africa | GCC |
| South Africa | ||
| Rest of Middle East and Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Bioinformatics Market Research FAQs
How big is the Bioinformatics Market?
The Bioinformatics Market size is expected to reach USD 16.36 billion in 2024 and grow at a CAGR of 7.94% to reach USD 23.97 billion by 2029.
What is the current Bioinformatics Market size?
In 2024, the Bioinformatics Market size is expected to reach USD 16.36 billion.
Who are the key players in Bioinformatics Market?
Illumina Inc., Thermo Fischer Scientific, Qiagen NV, PerkinElmer and Agilent Technologies are the major companies operating in the Bioinformatics Market.
Which is the fastest growing region in Bioinformatics Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Bioinformatics Market?
In 2024, the North America accounts for the largest market share in Bioinformatics Market.
What years does this Bioinformatics Market cover, and what was the market size in 2023?
In 2023, the Bioinformatics Market size was estimated at USD 15.16 billion. The report covers the Bioinformatics Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Bioinformatics Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Bioinformatics Industry Report
The Global Bioinformatics Services Market Growth & Insights report provides a comprehensive analysis of the market, segmented by products and services including knowledge management tools, bioinformatics platforms, and bioinformatics services. The applications covered in the report range from microbial genome, gene engineering, drug development, personalized medicine, omics, to other applications. The geographical segmentation includes North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
The report offers an industry analysis and a detailed industry outlook, highlighting the industry size, industry statistics, and industry trends. The market analysis delves into the market segmentation and market value, providing insights into market growth and market data. The report also includes a market forecast and market predictions, offering a market overview and market review.
Key aspects of the report include an analysis report and a report example, available as a report pdf. The industry reports and industry research sections provide valuable industry information and market leaders' insights. The research companies involved in the report ensure comprehensive market research and market analysis.
The market outlook discusses the growth rate and industry growth, supported by industry sales and market statistics. The industry profile and industry trends sections offer a detailed market overview, highlighting the market cap and market share. The market review and market overview sections provide a thorough analysis of market trends and market size.
In summary, the report is an essential resource for understanding the bioinformatics services market, offering a detailed analysis of industry data, market trends, and market segmentation. The report pdf is available for download, providing a valuable resource for industry professionals and market researchers.
